Home 2021

Archives

COVID-19 vaccines

COVID-19 vaccines: What you need to know

A critical intervention to help end the pandemic.     Scientists began work to develop a safe and effective vaccine soon after identifying the SARS-CoV-2 genome in...
Addressing-substance-disorder-healthcare-environment

Addressing substance use disorder and diversion in the healthcare environment

Early detection and response are key. Takeaways: Substance use disorder (SUD) affects people of all ages, genders, races, and religions regardless of socioeconomic status, professional...
covid-19-vaccine

COVID-19 Vaccine Errors – ISMP Issues Initial Report

Ever since the U.S. Food and Drug Administration granted emergency use authorization to the Pfizer-BioNTech and Moderna COVID-19 vaccines last month, the Institute for...

Pain in infants exposed to opioids during pregnancy

Infants exposed to opioids while their mothers were pregnant react more strongly to pain, according to a study in Journal of Maternal-Fetal & Neonatal...

Repetitive transcranial magnetic stimulation may improve memory

According to a study in PLoS ONE, repetitive transcranial magnetic stimulation improves memory. Read more at Duke University School of Medicine and access the...

Prescription drugs in pregnant and nursing women

On May 8, the FDA released two draft guidance documents designed to improve understanding of effects of prescription drugs in pregnant and nursing women. Read...

FDA approves treatment for two rare diseases

On May 6, the FDA approved Ruzurgi (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome in patients 6 to less than 17 years...

FDA approves first treatment for pediatric patients with lupus

On April 26, the FDA approved Benlysta (belimumab) I.V. infusion for treatment of children with systemic lupus erythematosus (SLE). This is the first FDA-approved...

FDA approves treatment for hepatitis C in children

On April 30, the FDA approved Mavyret (glecaprevir and pibrentasvir) tablets to treat all six genotypes of hepatitis C virus (HCV) in children ages...

FDA approves medical device for ADHD

On April 19, the FDA permitted marking of the first medical device to treat attention deficit hyperactivity disorder (ADHD): Monarch external Trigeminal Nerve Stimulation...

FDA approves generic naloxone nasal spray

On April 19, the FDA approved the first generic naloxone hydrochloride nasal spray (Narcan). Read more at fda.gov.

FDA approves first targeted therapy for bladder cancer

On April 12, the FDA approved Balversa (erdafitinib) for adult patients with locally advanced or metastatic bladder cancer that has a susceptible genetic alteration...

Lack of access to antibiotics is global challenge

Although overuse of antibiotics gets most of the attention, many people in low-and middle-income countries die because they lack access to antibiotics, according to...